Topical Treatment of Early Cutaneous T-cell Lymphoma
1995; Elsevier BV; Volume: 9; Issue: 5 Linguagem: Inglês
10.1016/s0889-8588(18)30057-1
ISSN1558-1977
AutoresDavid L. Ramsay, Jennifer A. Meller, Herschel S. Zackheim,
Tópico(s)Lymphoma Diagnosis and Treatment
ResumoThe two major topical treatment modalities for cutaneous T-cell lymphoma (CTCL) are mechlorethamine (nitrogen mustard) and topical carmustine (BCNU). Topical mechorethamine hydrochloride has been used since the late 1950s as therapy for CTCL. Topical BCNU solution is a highly effective treatment for early stage mycosis fungoides. This article describes these two modalities.
Referência(s)